SHIELD, EYE, SURGICAL

The contract requires the delivery of 2 packages, each containing 20 surgical eye shields, totaling 40 units, as specified by the NSN 6515-01-113-2653. Each shield is a single-use, cloth overall with an adhesive backing, designed to provide secure, gentle, and total eye occlusion, with a horizontal axis of 3 inches and a vertical axis of 2 inches. The item is classified under NAICS 339112 and is procured under solicitation SPE2DS-26-T-033V for performance at Eglin AFB, Florida, with delivery expected within 20 days of award. The packaging must comply with MIL-STD-2073-1E for preservation and Medical Marking Standard No. 1 for labeling and barcoding, which supersedes MIL-STD-129 for medical items, except in cases involving radioactive materials. FOB destination terms apply, and shipments must be traceable, with parcel post prohibited. All supplies must meet the technical and quality requirements listed in the DLA Master List of Technical and Quality Requirements, and bidders must specify their source and part number. The contract incorporates multiple FAR and DFARS clauses requiring strict compliance with cybersecurity, information safeguarding, and sourcing restrictions. Key among these is 252.204-7012, which mandates implementation of NIST SP 800-171 controls for systems handling Covered Defense Information, including cyber incident reporting within 72 hours and posting of assessment scores to the Supplier Performance Risk System. All subcontractors must flow down these requirements, and the use of equipment from covered foreign telecommunications vendors is prohibited under 252.204-7018. Contracting officers will determine the contract type, with offerors permitted to propose alternatives. Invoicing must be processed via WAWF, and packaging must include proper government identification that may be removed from non-accepted items. Offerors must provide UEI and CAGE codes and represent their size status and socioeconomic certifications, with proposals submitted electronically via DIBBS by May 6, 2026. The item is medically regulated and subject to FDA oversight, with all acceptance criteria tied to compliance with the referenced technical standards, even though no formal inspection section specifies procedures. Payment details, accounting codes, and COTR/PCO contacts will be finalized upon award.